Analysen von James Gordon
| 13.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.07.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.06.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | Sanofi Underweight | JP Morgan Chase & Co. | |
| 31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.03.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 03.03.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 29.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 19.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 22.01.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.12.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 20.11.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.11.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.11.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 27.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.09.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 09.09.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.07.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 20.07.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 23.06.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 10.06.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.06.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.05.15 | GSK verkaufen | JP Morgan Chase & Co. | |
| 14.05.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.05.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 22.04.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.04.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |